Literature DB >> 21078914

Prediction of reactivity to noninherited maternal antigen in MHC-mismatched, minor histocompatibility antigen-matched stem cell transplantation in a mouse model.

Mariko Araki1, Masahiro Hirayama, Eiichi Azuma, Tadashi Kumamoto, Shotaro Iwamoto, Hidemi Toyoda, Mitsue Ito, Keishiro Amano, Yoshihiro Komada.   

Abstract

The immunologic effects of developmental exposure to noninherited maternal Ags (NIMAs) are quite variable. Both tolerizing influence and inducing alloreaction have been observed on clinical transplantation. The role of minor histocompatibility Ags (MiHAs) in NIMA effects is unknown. MiHA is either matched or mismatched in NIMA-mismatched transplantation because a donor of the transplantation is usually limited to a family member. To exclude the participation of MiHA in a NIMA effect for MHC (H-2) is clinically relevant because mismatched MiHA may induce severe alloreaction. The aim of this study is to understand the mechanism of NIMA effects in MHC-mismatched, MiHA-matched hematopoietic stem cell transplantation. Although all offsprings are exposed to the maternal Ags, the NIMA effect for the H-2 Ag was not evident. However, they exhibit two distinct reactivities, low and high responder, to NIMA in utero and during nursing depending on the degree of maternal microchimerism. Low responders survived longer with less graft-versus-host disease. These reactivities were correlated with Foxp3 expression of peripheral blood CD4(+)CD25(+) cells after graft-versus-host disease induction and the number of IFN-γ-producing cells stimulated with NIMA pretransplantation. These observations are clinically relevant and suggest that it is possible to predict the immunological tolerance to NIMA.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21078914     DOI: 10.4049/jimmunol.1001226

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

1.  Major and minor histocompatibility antigens to NIMA: Prediction of a tolerogenic NIMA effect.

Authors:  Masahiro Hirayama; Eiichi Azuma
Journal:  Chimerism       Date:  2011-01

Review 2.  Maternal-fetal cellular trafficking: clinical implications and consequences.

Authors:  Cerine Jeanty; S Christopher Derderian; Tippi C Mackenzie
Journal:  Curr Opin Pediatr       Date:  2014-06       Impact factor: 2.856

3.  Pretransplant immune-regulation predicts allograft tolerance.

Authors:  P Dutta; M Dart; D A Roenneburg; J R Torrealba; W J Burlingham
Journal:  Am J Transplant       Date:  2011-03-30       Impact factor: 8.086

4.  Chimeric maternal cells in offspring do not respond to renal injury, inflammatory or repair signals.

Authors:  Jesús M López-Guisa; Rebecca Howsmon; Andrew Munro; Kendall M Blair; Edward Fisher; Heidi Hermes; Richard Zager; Anne M Stevens
Journal:  Chimerism       Date:  2011-04

5.  Cross-Generational Reproductive Fitness Enforced by Microchimeric Maternal Cells.

Authors:  Jeremy M Kinder; Tony T Jiang; James M Ertelt; Lijun Xin; Beverly S Strong; Aimen F Shaaban; Sing Sing Way
Journal:  Cell       Date:  2015-07-23       Impact factor: 41.582

6.  A feasibility study on the prediction of acute graft-vs.-host disease before hematopoietic stem cell transplantation based on fetomaternal tolerance.

Authors:  Masahiro Hirayama; Eiichi Azuma; Tsuyoshi Ito; Yoshitaka Keida; Yoshihiro Komada
Journal:  Chimerism       Date:  2013-09-12

7.  Tolerogenic effect of non-inherited maternal antigens in hematopoietic stem cell transplantation.

Authors:  Masahiro Hirayama; Eiichi Azuma; Yoshihiro Komada
Journal:  Front Immunol       Date:  2012-05-25       Impact factor: 7.561

8.  Neutrophils induced licensing of natural killer cells.

Authors:  Keishiro Amano; Masahiro Hirayama; Eiichi Azuma; Shotaro Iwamoto; Yoshitaka Keida; Yoshihiro Komada
Journal:  Mediators Inflamm       Date:  2015-04-21       Impact factor: 4.711

Review 9.  Tolerance to noninherited maternal antigens, reproductive microchimerism and regulatory T cell memory: 60 years after 'Evidence for actively acquired tolerance to Rh antigens'.

Authors:  Jeremy M Kinder; Tony T Jiang; James M Ertelt; Lijun Xin; Beverly S Strong; Aimen F Shaaban; Sing Sing Way
Journal:  Chimerism       Date:  2015-10-30

Review 10.  How do we choose the best donor for T-cell-replete, HLA-haploidentical transplantation?

Authors:  Ying-Jun Chang; Leo Luznik; Ephraim J Fuchs; Xiao-Jun Huang
Journal:  J Hematol Oncol       Date:  2016-04-12       Impact factor: 17.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.